Andrew M. Intlekofer, MD, PhD

About Me

I am a medical oncologist with expertise in caring for people with all types of lymphoma, with a particular interest in T cell lymphoma. My clinical research focuses on identifying genetic abnormalities that cause lymphoma and translating that knowledge to improve care for people with lymphoma. My laboratory research investigates how deregulated metabolic pathways contribute to cancer development and how metabolic enzymes can be targeted for cancer treatment.

Read more
  • Clinical Expertise: Hodgkin and Non-Hodgkin Lymphomas; T Cell Lymphomas; Mechanism-Based Therapies
  • Languages Spoken: English
  • Education: MD, PhD, University of Pennsylvania School of Medicine
  • Residencies: NewYork-Presbyterian Hospital/Weill Cornell Medical College
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues


Visit PubMed for a full listing of Andrew M. Intlekofer’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more